Athersys reports positive data from MultiStem cell therapy trial and CRISPR and Vertex treat first patient in gene-editing therapy trial. Clinicaltrialsarena.com wraps up the key headlines from 2019.
NIH kick starts hunt for neuroprotective stroke treatments and Denali begins dosing Parkinson’s patients in Phase Ib trial. Clinicaltrialsarena.com wraps up the key headlines from September 2019.
IQVIA has collaborated with Friends of Cancer Research to advance the use of real-world evidence (RWE) in clinical trials to better understand treatment outcomes over time.
Shanghai Mental Health Center (SMHC) has selected Signant Health to provide electronic informed consent for a neuroscience study on schizophrenia.
The National Institute of Aging (NIA) will invest up to $53.4m over five years to spur innovation and enhance care for people suffering from Alzheimer’s disease and related dementias.
Give your business an edge with our leading industry insights.
Sweden-based AMRA Medical will support its pharmaceutical and research customers in carrying out clinical trials in Japan after partnering with imaging contract research organisation (CRO) Micron.
The University of Kansas Cancer Center and the Midwest Cancer Alliance has received a six-year grant to expand its clinical trials to rural communities in the US state of Kansas.
The University of California, Irvine’s (UC Irvine) Institute for Clinical & Translational Science has received a grant of $24m from the National Institutes of Health.
The US National Institute of Health (NIH) has launched a search for neuroprotective therapies to reduce ischemic brain injury.
Switzerland-based Idorsia Pharmaceuticals has selected Arkivum to protect and digitally store its clinical trial and research data.